|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
MISSISSAUGA, ON, April 12, 2017 /CNW/ - Cipher Pharmaceuticals Inc. (CPH.TO) ("Cipher" or "the Company") today announced several proposed changes to its Board of Directors, to be voted upon at the Company's Annual Meeting on May 11, 2017. Robert Tessarolo, who will become Cipher's President and Chief Executive Officer on April 17, 2017, and Arthur Deboeck, Vice-President and General Manager of Galephar Pharmaceutical Research, Inc. ("Galephar"), Cipher's strategic partner, are being proposed for election to Cipher's Board of Directors.
TORONTO, March 21, 2017 /CNW/ - Trading resumes in: Company: Namaste Technologies Inc. CSE Symbol: N Resumption (ET): 10:15 AM IIROC can make a decision to impose a temporary suspension (halt) of trading ...